BRIEF — CSPC Pharmaceutical Says SYS6088 Injection Obtains Clinical Trial Approval In China
Oct 15 (Reuters) — CSPC PHARMACEUTICAL GROUP LIMITED: Pharma's Sys6088 Injection Obtains Clinical Trial Approval In China Further company coverage: 1093.HK (Reuters.Briefs@thomsonreuters.com;)